We sought to rationally design Degraders with dual activity against BRD4 and CBP/p300, using the parent inhibitor compound ISOX DUAL. X-ray co-crystal structures informed selection of two potential exit vectors, which were explored for Degrader design. Several compounds displayed dual inhibitory activity, albeit in many cases with reduced affinity for one or both target proteins, in biochemical assays.